Nachrichten zur Myriad Genetics Inc. Aktie

Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Q2 Loss

Strong testing volume improvement across all businesses drives Myriad Genetics (MYGN) Q2 performance....…

Myriad Genetics Inc. Q2 Earnings Summary

WASHINGTON (dpa-AFX) - Below are the earnings highlights for Myriad Genetics Inc. (MYGN):Earnings: -$116.1 million in Q2 vs. -$14.1 million…

Myriad Genetics to Release Second Quarter Financial Results on Aug. 3, 2023

SALT LAKE CITY, July 27, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment

RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers...…

Myriad Genetics announces $90M asset-based credit facility

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K MYRIAD GENETICS INC For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and response Myriad to support MD Anderson…

Myriad Genetics to Participate in Goldman Sachs Healthcare Conference

SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

Insiderhandel: Aufsichtsrat verkauft Aktien von Myriad Genetics im Wert von 198.760$

Spiegelman, Daniel K. - Aufsichtsrat - Tag der Transaktion: 2023-06-02...…

Form 8-K MYRIAD GENETICS INC For: Jun 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics

SALT LAKE CITY, May 31, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio

Myriad Genetics (MYGN) expands Precise Oncology Solutions portfolio by adding a new biomarker test....…

Goldman Sachs Maintains Myriad Genetics Buy Recommendation

Goldman Sachs has maintained coverage of Myriad Genetics with a Buy recommendation....…

Goldman Sachs Upgrades Myriad Genetics

Goldman Sachs has upgraded its outlook for Myriad Genetics to Buy....…

Myriad Genetics rises as Goldman upgrades on growth potential

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myriad Genetics Soars on Double Upgrade from Goldman

Analysts say they expect the company to be operating cash flow positive in 2023....…

Myriad Genetics Earns 2023 Great Place to Work Certification™

SALT LAKE CITY, May 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

Myriad Genetics Inc. Q1 Loss Increases, misses estimates

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) announced Loss for its first quarter that increased from the same period last…

Myriad Genetics reports Q1 results, narrows FY 2023 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunovia AB appoints new CEO

April 29, 2023, Lund, Sweden LUND, SWEDEN – As a next step in focusing on the US market The Board of Directors…

Myriad Genetics (MYGN) Gets Permit to Expand Tumor Testing

Myriad Genetics (MYGN) and Intermountain Precision Genomics receive the New York State Clinical Laboratory Permit to offer solid tumor testing…

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey

Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanisms Medication failure leads 45% of…

Myriad Genetics and Intermountain Precision Genomics Now Offer Solid Tumor Testing in All 50 States with Latest NY State Certification

Intermountain Precision Genomics Laboratory receives certification from NYS Department of Health Clinical Laboratory Evaluation Program Intermountain Precision Genomics Laboratory receives…

Myriad Genetics, SimonMed to launch hereditary cancer test program

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Operating Officer verkauft Aktien von Myriad Genetics im Wert von 151.047$

Lambert, Nicole - Vorstand - Tag der Transaktion: 2023-03-27...…

Illumina, Myriad Genetics expand partnership to broaden access to HRD testing in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry Strategic partnership offers a…

Myriad Genetics surges 15% amid strong 2023 guidance, quarterly top and bottom line beats

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myriad Genetics (MYGN) Q4 Earnings Top, Gross Margin Falls

Myriad Genetics (MYGN) hereditary cancer testing volume registered strong growth in the fourth quarter. GeneSight comes up with yet another…

Form 10-K MYRIAD GENETICS INC For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myriad Genetics (MYGN) Reports Q4 Loss, Tops Revenue Estimates

Myriad (MYGN) delivered earnings and revenue surprises of 25% and 5.11%, respectively, for the quarter ended December 2022. Do the…

Myriad Genetics Inc. Q4 Loss Increases, but beats estimates

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released Loss for its fourth quarter that increased from last year and missed…

Myriad Genetics Non-GAAP EPS of -$0.12 beats by $0.05, revenue of $177.8M beats by $8.38M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myriad Genetics Q4 2022 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Earnings Preview For Myriad Genetics

Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023

SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

United States Women Health Laboratory Testing Markets Report 2022-2030 Featuring Ascension, EKF, Gateway Genomics, Laboratory Corp of America, Myriad Genetics, Natera, Ovia Health, Roche, & Yourgene

DUBLIN, Feb. 20, 2023 /PRNewswire/ -- The "U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S.…

Myriad Genetics to Participate in Upcoming Healthcare Conferences

SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…

dpa-AFX ProFeed